13 completed. 13 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 13 | Completed 13 |
Follow Transdermal Patch: new trials by email Literature Review of Transdermal Patch trials Research Report on Transdermal Patch
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Postmarketing Open-Label Study to Assess Residual Levonorgestrel (LNG) and Ethinyl Estradiol (EE) Content of TWIRLA® (Levonorgestrel and Ethinyl Estradiol) Transdermal System Twirla® (Levonorgestrel/Ethinyl Estradiol) Transdermal System - Residual Drug Amount of EE and LNG | Phase 4 | Completed | Insud Pharma | 28 | 2021-10-25 | 2026-08-27 |
| Evaluation of Mucoadhesive Tacrolimus Patch on Caspase-3 Inducing Apoptosis in Oral Lichen Planus Corticosteroid Topical - Oral Lichen Planus | Phase 4 | Completed | Ain Shams University | 30 | 2019-05-20 | 2021-12-01 |
| The Efficacy and Safety Profile of Capsaicin 8% Patch Versus 5% Lidocaine Patch in Males With Diabetic Neuropathy Lidocaine 5% patch, Capsaicin 8% Patch, Per 10 Square Centimeters - Diabetic Nerve Problems, Diabetic Neuropathy | Phase 4 | Completed | Corporacion Parc Tauli | 290 | 2019-01-10 | 2020-01-30 |
| Pharmacokinetics of Lidocaine in Healthy Adults Lidocaine 5% patch, Lidocaine hydrochloride, Lidoderm 5% patch - Healthy | Phase 4 | Completed | Nicole K Brogden | 23 | 2018-03-14 | 2021-11-01 |
| Post-Op Lidocaine Patch Lidoderm 5 % Topical Patch, Sham Topical Patch - Pain, Postoperative | Phase 4 | Completed | Oregon Health and Science University | 50 | 2018-03-13 | 2020-03-11 |
| Mobile Health Technology to Enhance Abstinence in Smokers With Schizophrenia Nicotine replacement therapy, Bupropion, cognitive-behavioral smoking cessation counseling - Schizophrenia, Cigarette Smoking | Phase 4 | Completed | Duke University | 35 | 2017-03-27 | 2019-07-10 |
| Mobile Contingency Management for Concurrent Abstinence From Alcohol and Smoking Nicotine Replacement Therapy, Bupropion, Cognitive Behavioral Treatment - Smoking Cessation, Alcohol Drinking | Phase 4 | Completed | Duke University | 45 | 2016-11-01 | 2021-04-28 |
| Nicotine Replacement Therapy in the Intensive Care Unit Transdermal nicotine patch, Cutaneous patch, containing no active substances - Delirium, Psychomotor Agitation | Phase 4 | Completed | Gelderse Vallei Hospital | 47 | 2012-06-01 | 2018-10-10 |
| Method of Pre-treatment for Application of QUTENZA Capsaicin 8% Patch QUTENZA, Lidocaine, Tramadol - or Peripheral Nerve Injury (PNI), Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) | Phase 4 | Completed | Astellas Pharma Inc | 122 | 2011-07-06 | 2018-04-23 |
| Evaluation of Treatments to Improve Smoking Cessation Medication Adherence Short Term Combination Nicotine Replacement Therapy (patch + gum), Long Term Combination Nicotine Replacement Therapy (patch + gum), Intensive Maintenance Counseling - Smoking, Smoking Cessation | Phase 4 | Completed | University of Wisconsin, Madison | 544 | 2010-06-01 | 2015-12-11 |
| FS-67 in the Treatment of Pediatric Patients With Ankle Sprain FS-67 Patch, Placebo Patch - Ankle Sprain | Phase 4 | Completed | Hisamitsu Pharmaceutical Co., Inc. | 252 | 2009-12-01 | 2022-10-06 |
| Varenicline Versus Transdermal Nicotine Patch for Smoking Cessation in Patients With Coronary Heart Disease Varenicline, Transdermal Nicotine Patch - Coronary Heart Disease | Phase 4 | Completed | Ottawa Heart Institute Research Corporation | 50 | 2009-04-01 | 2026-05-28 |
| Smoking Cessation Intervention: Effectiveness in Primary Care nicotine patch, nicotine lozenge, bupropion - Tobacco Dependence | Phase 4 | Completed | University of Wisconsin, Madison | 1346 | 2004-09-01 | 2015-10-14 |
Smoking Cessation (3) · Tobacco Use Disorder (2) · Alcohol Drinking (1) · Ankle Injuries (1) · Cardiovascular Diseases (1) · Cigarette Smoking (1) · Coronary Disease (1) · Delirium (1) · Diabetic Neuropathies (1) · Lichen Planus, Oral (1) · Pain, Postoperative (1) · Peripheral Nerve Injuries (1) · Psychomotor Agitation (1) · Schizophrenia (1) · Smoking (1)
Duke University (2) · University of Wisconsin, Madison (2) · Ain Shams University (1) · Astellas Pharma Inc (1) · Corporacion Parc Tauli (1) · Gelderse Vallei Hospital (1) · Hisamitsu Pharmaceutical Co., Inc. (1) · Insud Pharma (1) · Nicole K Brogden (1) · Oregon Health and Science University (1) · Ottawa Heart Institute Research Corporation (1)
United States (8) · Belgium (1) · Canada (1) · Czechia (1) · Denmark (1) · Egypt (1) · Ireland (1) · Netherlands (1) · Norway (1) · Pakistan (1) · Slovakia (1) · United Kingdom (1)
Andrew Pipe, MD (1) · Ben Jong,de, MD (1) · Catherine Leclair, MD (1) · Eric A. Dedert, Ph.D. (1) · Jean C Beckham, Ph.D. (1) · Michael C Fiore, MD, MPH, MBA (1) · Nicole K Brogden, PharmD, PhD (1) · Robert Reid, PhD MBA (1) · Tanya R Schlam, PhD (1) · Thomas C Jackson, MD (1) · Yoshinobu Higashi (1)
PMID 20008701, PMID 22608375, PMID 29696311, PMID 29881956, PMID 32598468, PMID 36788511, PMID 37142273, PMID 37335995
P50CA143188 (1), P50DA019706 (1)